Sector Chart Enimmune corporation

Stocks

6564

TW0006564008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 30/10/2026			5-day change	1st Jan Change
14.90 ^TWD	-2.61%		-7.17%	-27.67%

10-15	Duopharma Biotech Berhad Signs Five-Year Exclusive Distribution Agreement with Enimmune Corporation in Malaysia	CI
08-12	Enimmune Corporation Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes